Alteco Medical in the business of extracorporeal adsorption of human toxins in acute and planned hospital treatments. Our mission is to safely stabilize patients in toxic immune response situations. Alteco Medical AB provides a solution for hospitals across the world to remove endotoxin(lipopolysaccharides, LPS) in the patient’s bloodstream to counteract the threat of endotoxemia during their hospital stay. Our Alteco® LPS Adsorber contains a peptide that binds to Lipid A, the toxic part of LPS. Endotoxemia can lead to sepsis and septic shock – one of the most common causes of death in modern intensive care units. The Alteco® LPS Adsorber can be used as counteraction when endotoxemia is suspected, or there is a risk of endotoxemia, in complement to best-practice medical treatment (e.g. antibiotics).
Since 2007, the Alteco® LPS Adsorber is a class IIa, CE-marked medical device. It is safely used during hemoperfusion with no contraindications, no reported side effects or serious adverse events.
Alteco Medical AB is an ISO 13485 certified medical device company founded in 2002 and is located in Lund, Sweden.